The best FDA-approved at-home COVID tests
Aol.· 2 days agoSome tests are rapid at-home antigen tests that give results in as little as 10 minutes, while other at-home tests are polymerase chain reaction ...
You Can Now Get Free COVID-19 and Flu Tests and Treatments at Home
Verywell Health via Yahoo News· 2 hours agoIf you test positive for either disease, regardless of where you took the test, you can get a free...
Toddler, 2, dies from rare pigeon virus — only the 5th person to do so
New York Post· 1 day agoDoctors ran a multitude of tests, including magnetic resonance imaging (MRI), autoimmune...
Whenever, Wherever: Taking DNA Amplification Outside the Lab
The Scientist· 5 days agoIn 2006, researchers Olaf Piepenburg, Colin Williams, and Niall Armes of ASM Scientific, which later...
COVID-19 kills 4 more in N.B., flu sends 8 to hospital
CBC via Yahoo News· 3 days agoCOVID-19 has killed four more New Brunswickers, while flu activity has spiked again, sending eight...
N.B. has no plan to offer drive-thru COVID-19 and flu vaccines, like at N.S. hospital
CBC via Yahoo News· 5 days agoNova Scotia is offering drive-thru COVID-19 and flu vaccines at Dartmouth General Hospital, but New...
Study: School air sampling worked as well as other methods in tracking COVID, flu
Center for Infectious Disease Research and Policy· 3 days agoThe team compared air sampling with home-based reverse transcription-polymerase chain reaction...
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
Morningstar· 1 day ago- Conference Call/Webcast Scheduled for Today at 4:30 PM ET -STONY BROOK, NY / ACCESSWIRE / December 7, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader ...
Study highlights complications of mpox, chickenpox co-infections
Center for Infectious Disease Research and Policy· 1 day agoAlmost 30% of mpox patients described in a retrospective study from Nigeria were co-infected with...
OpGen (NASDAQ:OPGN) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the medical research company ...